...
首页> 外文期刊>Radiology >Rectal Cancer: Assessment of Complete Response to Preoperative Combined Radiation Therapy with Chemotherapy--Conventional MR Volumetry versus Diffusion-weighted MR Imaging.
【24h】

Rectal Cancer: Assessment of Complete Response to Preoperative Combined Radiation Therapy with Chemotherapy--Conventional MR Volumetry versus Diffusion-weighted MR Imaging.

机译:直肠癌:评估术前联合放疗与化学疗法的完全反应-常规MR量与弥散加权MR成像。

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To determine diagnostic performance of diffusion-weighted (DW) magnetic resonance (MR) imaging for assessment of complete tumor response (CR) after combined radiation therapy with chemotherapy (CRT) in patients with locally advanced rectal cancer (LARC) by means of volumetric signal intensity measurements and apparent diffusion coefficient (ADC) measurements and to compare the performance of DW imaging with that of T2-weighted MR volumetry. Materials and Methods: A retrospective analysis of 50 patients with LARC, for whom clinical and imaging data were retrieved from a previous imaging study approved by the local institutional ethical committee and for which all patients provided informed consent, was conducted. Patients underwent pre- and post-CRT standard T2-weighted MR and DW MR. Two independent readers placed free-hand regions of interest (ROIs) in each tumor-containing section on both data sets to determine pre- and post-CRT tumor volumes and tumor volume reduction rates (volume). ROIs were copied to an ADC map to calculate tumor ADCs. Histopathologic findings were the standard of reference. Receiver operating characteristic (ROC) curves were generated to compare performance of T2-weighted and DW MR volumetry and ADC. The intraclass correlation coefficient (ICC) was used to evaluate interobserver variability and the correlation between T2-weighted and DW MR volumetry. Results: Areas under the ROC curve (AUCs) for identification of a CR that was based on pre-CRT volume, post-CRT volume, and volume, respectively, were 0.57, 0.70, and 0.84 for T2-weighted MR versus 0.63, 0.93, and 0.92 for DW MR volumetry (P = .15, .02, .42). Pre- and post-CRT ADC and ADC AUCs were 0.55, 0.54, and 0.51, respectively. Interobserver agreement was excellent for all pre-CRT measurements (ICC, 0.91-0.96) versus good (ICC, 0.61-0.79) for post-CRT measurements. ICC between T2-weighted and DW MR volumetry was excellent (0.97) for pre-CRT measurements versus fair (0.25) for post-CRT measurements. Conclusion: Post-CRT DW MR volumetry provided high diagnostic performance in assessing CR and was significantly more accurate than T2-weighted MR volumetry. Post-CRT DW MR was equally as accurate as volume measurements of both T2-weighted and DW MR. Pre-CRT volumetry and ADC were not reliable. (c) RSNA, 2011.
机译:目的:确定弥散加权(DW)磁共振(MR)成像对局部晚期直肠癌(LARC)患者进行放射治疗与化学疗法(CRT)联合治疗后评估完整肿瘤反应(CR)的诊断性能体积信号强度测量和视在扩散系数(ADC)测量,并比较DW成像和T2加权MR体积测量的性能。材料和方法:对50例LARC患者进行了回顾性分析,从当地机构伦理委员会批准的先前影像学研究中检索了临床和影像学数据,所有患者均获得了知情同意。患者接受CRT之前和之后的标准T2加权MR和DW MR。两个独立的阅读器在两个数据集的每个包含肿瘤的区域中放置了感兴趣的自由区域(ROIs),以确定CRT前后的肿瘤体积和肿瘤体积缩小率(体积)。将ROI复制到ADC图以计算肿瘤ADC。组织病理学发现是参考标准。生成了接收器工作特性(ROC)曲线,以比较T2加权和DW MR容量计和ADC的性能。类内相关系数(ICC)用于评估观察者之间的变异性以及T2加权和DW MR容量之间的相关性。结果:基于CRT之前的体积,CRT后的体积和体积的ROC曲线(AUC)下用于识别CR的面积分别为T2加权MR的0.57、0.70和0.84,而0.63、0.93 ,对于DW MR体积,则为0.92(P = .15,.02,.42)。 CRT之前和之后的ADC和ADC AUC分别为0.55、0.54和0.51。观察者之间的协议对于所有CRT之前的测量(ICC,0.91-0.96)都非常好,而CRT之后的测量则很好(ICC,0.61-0.79)。 CRT前测量的T2加权和DW MR容积之间的ICC极好(0.97),而CRT后测量的ICC很好(0.25)。结论:CRT后DW MR容量测定仪在评估CR方面具有很高的诊断性能,并且比T2加权MR容量测定仪准确得多。 CRT后的DW MR与T2加权和DW MR的体积测量一样准确。 CRT之前的容量和ADC不可靠。 (c)RSNA,2011年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号